1. Home
  2. NTHI vs VUZI Comparison

NTHI vs VUZI Comparison

Compare NTHI & VUZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • VUZI
  • Stock Information
  • Founded
  • NTHI 2008
  • VUZI 1997
  • Country
  • NTHI United States
  • VUZI United States
  • Employees
  • NTHI N/A
  • VUZI 76
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • VUZI Industrial Machinery/Components
  • Sector
  • NTHI Health Care
  • VUZI Technology
  • Exchange
  • NTHI Nasdaq
  • VUZI Nasdaq
  • Market Cap
  • NTHI 155.4M
  • VUZI 183.3M
  • IPO Year
  • NTHI N/A
  • VUZI N/A
  • Fundamental
  • Price
  • NTHI $11.00
  • VUZI $2.48
  • Analyst Decision
  • NTHI
  • VUZI
  • Analyst Count
  • NTHI 0
  • VUZI 0
  • Target Price
  • NTHI N/A
  • VUZI N/A
  • AVG Volume (30 Days)
  • NTHI 87.3K
  • VUZI 1.3M
  • Earning Date
  • NTHI 08-19-2025
  • VUZI 11-13-2025
  • Dividend Yield
  • NTHI N/A
  • VUZI N/A
  • EPS Growth
  • NTHI N/A
  • VUZI N/A
  • EPS
  • NTHI N/A
  • VUZI N/A
  • Revenue
  • NTHI $59,990.00
  • VUZI $5,534,768.00
  • Revenue This Year
  • NTHI N/A
  • VUZI $22.67
  • Revenue Next Year
  • NTHI N/A
  • VUZI $80.00
  • P/E Ratio
  • NTHI N/A
  • VUZI N/A
  • Revenue Growth
  • NTHI N/A
  • VUZI N/A
  • 52 Week Low
  • NTHI $3.20
  • VUZI $0.85
  • 52 Week High
  • NTHI $25.00
  • VUZI $5.79
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • VUZI 61.58
  • Support Level
  • NTHI N/A
  • VUZI $2.12
  • Resistance Level
  • NTHI N/A
  • VUZI $2.38
  • Average True Range (ATR)
  • NTHI 0.00
  • VUZI 0.16
  • MACD
  • NTHI 0.00
  • VUZI 0.03
  • Stochastic Oscillator
  • NTHI 0.00
  • VUZI 87.80

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

Share on Social Networks: